Abstract
Calcitonin was discovered 20 years ago and was first regarded as an osteotropic hypocalcemic hormone, antagonizing parathyroid hormone (Copp 1969). Later, the stimulation of calcitonin secretion by gastrointestinal hormones and the inhibition of the function of several gastrointestinal organs were described (for review, see Ziegler 1981). Presumably, calcitonin is a calcium-conserving hormone at least in mammals. Calcitonin was detected not only in the thyroid C cells, originating from the terminal branchial pouch, but also in the thymus, adrenals, lungs, and the brain (MacIntyre and Stevenson 1981), depending on the species investigated. The hormone is found in primitive prevertebrate organisms, such as Ciona intestinalis, and it is possible that, primarily, it exerts neuroendocrine functions. Later in phylogenesis, it becomes involved in the regulation of bone metabolism after the development of mineralized hard tissue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barreca T, Cicchetti M, Magnani G, Sannia A, Rolandi E (1979) Effects of long-term treatment with porcine calcitonin in patients suffering from neoplastic osteolysis. Curr Ther Res 26: 644–649
Behn AR, West TET (1977) Emergency treatment with calcitonin of hypercalcemia associated with multiple myeloma. Br Med J 1: 755–756
Braga P, Ferri S, Santagostino A, Olgiati VR, Pecile A (1978) Lack of opiate receptor involvement in centrally induced calcitonin analgesia. Life Sci 22: 971–978
Cesarini F, Colombo M, Olgiati VR, Pecile A (1979) Calcitonin and prostaglandin systems. Life Sci 25: 1851
Chiarini P, Matassi L, Fabrizi G (1978) Calcitonin and somatic pain: effect of the hormone on the algogenic component of experimental skin inflammation induced by cantharidin. Curr Ther 86: 451–463
Copp DH (1969) Endocrine control of calcium homeostasis. J Endocrinol 43: 137–161
Di Silverio F, Giacobini S, Liberti M, Fragomeri R, Petrone U (1977) Impiego della calcitonia nelle metastasi ossie da carcinoma della prostata. Clin Ter 83: 3–15
Fabbri A, Santoro C, Moretti C, Cappa M, Fraioli F, Di Julio GP, Galluzi T, La Manna V (1981) The analgesic effect of calcitonin in humans: studies on the role of opioid peptides. Int J Clin Pharmacol Ther Toxicol 19: 509–511
Favini G, Arosio A, Libretti A (1979) Bone metastases from breast cancer treated with calcitonin. Case report. Tumori 65: 713–717
Gennari C (1980) Calcitonin and bone metastases of cancer. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 277–287
Goebell H, Amman R, Herfarth Ch, Horn J, Hotz J, Knoblauch M, Schmid M, Jaeger M, Akovbiantz A, Linder E, Abt K, Nüesch E, Barth EA (1979) A double blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol 14: 881–889
Kanis JA (1976) Bone disease and calcitonin. Armour, Eastbourne Leyland MJ, Hindley A (1982) Calcitonin in the management of malignant bone pain. Clin Sci 62: 43 P
Maclntyre I (1977) Human calcitonin and Paget’s disease. Huber, Bern
MacIntyre I, Stevenson JC (1981) Calcitonin: a modern view of its physiological role and interrelation with other hormones. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 1–10
Nakamuta H, Furukawa S, Koida M, Yajima H, Orlowski RC, Schlueter R (1981) Specific binding of 1-salmon calcitonin to rat-brain: regional variation and calcitonin specificity. Jpn J Pharmacol 31: 53–60
Paul F, Ohnhaus EE, Hesch RD, Chemnitz G, Hoppe-Seyler R, Henrichts HR, Hartung H, Waldmann D, Kunzek K, Barth E, Nüesch E, Abt K (1979) Einfluß von Salm-Calcitonin auf den Verlauf der akuten Pankreatitis. Dtsch Med Wochenschr 104: 615–622
Pecile A, Ferri S, Santagostino A, Olgiati VR (1975) Effects of intraventricular calcitonin in the conscious rat. Experientia 31: 332–333
Pietrogrande V (1976) Il trattamento dell’ osteoporosi con Calcitonina. Fondazione Carlo Erba, Milano
Rojanasathit S, Rosenberg E, Haddad JG (1974) Paget’s bone disease: response to human calcitonin in patients resistant to salmon calcitonin. Lancet 2: 1412–1415
Schedel I (1982) Calcitonin bei Knochenschmerzen bei multiplem Myelom. Symposium Beeinflussung von Schmerzen durch Calcitonin, Heidelberg, 20 May 1982 (abstract)
Vignon E, Chapuy MC, Courpron P, Colombet P, Meunier P (1977) Effets cliniques et biologiques de la calcitonine synthétique de saumon dans les algodystrophies des membres. Lyon Med 237: 291–295
Welzel D (1982) Postoperative Schmerzen. Symposium-Beeinflussung von Schmerzen durch Calcitonin, Heidelberg, 20 May 1982 (abstract)
Yamamoto M, Kumagai F, Tachikawa S, Murayama S (1978) Effects of porcine calcitonin on various analgesic responses in mice and rabbits. Ciba Med J 54: 27–33
Yamamoto M, Kumagai F, Tachikawa S, Maeno H (1979) Lack of effect of levallorphan on analgesia induced by intraventricular application of porcine calcitonin in mice. Eur J Pharmacol 55: 211–213
Ziegler R (1981) Calcitonin. Sandoz, Nürnberg
Ziegler R, Holz G, Raue F, Minne H, Delling G (1977) Therapeutic studies with human calcitonin. In: Maclntyre J (ed) Human calcitonin and Paget’s disease. Huber, Bern, pp 167–178
Ziegler R, Raue F, Holz G, Minne H (1980) Calcitonin and the endocrine pancreas. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 314–325
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Ziegler, R. (1984). Calcitonin: Analgesic Effects. In: Zimmermann, M., Drings, P., Wagner, G. (eds) Pain in the Cancer Patient. Recent Results in Cancer Research, vol 89. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82028-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-82028-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82030-4
Online ISBN: 978-3-642-82028-1
eBook Packages: Springer Book Archive